Latest Healthcare Research Reports

Author: The Business Research Company

How Is The Hepatitis Drugs Market Expected To Grow Through 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Hepatitis Drugs Global Market Report 2024, the hepatitis drugs market is expected to show promising growth in the forecast period.

Steady Growth and Projections
The hepatitis drugs market has been experiencing a steady growth trajectory, with the market size increasing from $19.34 billion in 2023 to $20.28 billion in 2024, boasting a compound annual growth rate (CAGR) of 4.9%. Looking ahead, the market is poised to continue its ascent, projected to reach $23.92 billion in 2028, showcasing a CAGR of 4.2%. These upward trends are fueled by various factors, including technological advancements and global initiatives.

Factors Driving Growth in the Historic Period
- Discovery of antiviral drugs targeting hepatitis viruses
- Advances in diagnostic technologies for hepatitis
- Growing awareness of the global burden of hepatitis
- Expansion of hepatitis vaccination programs
- Development of interferon-based therapies for hepatitis
Factors Propelling Growth in the Forecast Period
- Introduction of novel direct-acting antiviral drugs
- Increasing prevalence of hepatitis infections
- Rise in government initiatives for hepatitis prevention and treatment
- Advances in personalized medicine approaches for hepatitis
- Expansion of access to hepatitis drugs in developing countries
Major Trends to Watch Out For
- Transition from interferon-based to interferon-free therapies
- Development of pan-genotypic antiviral drugs for hepatitis C
- Integration of non-invasive diagnostic methods for liver fibrosis assessment
- Exploration of combination therapies for hepatitis B
- Growing focus on the elimination of viral hepatitis as a public health threat
Rising Research and Development Investments: A Catalyst for Advancements
The hepatitis drugs market is set to benefit significantly from increased investments in research and development (R&D). R&D, a crucial driver of innovation and progress, has seen substantial funding globally. Notably, the Australian government plans to invest $12.1 billion in R&D in 2022–23, marking a 3.2% increase from the previous year. This boost in R&D investments is instrumental in advancing hepatitis drug development.

Key Players Shaping the Landscape
Several major companies play a pivotal role in the hepatitis drugs market. These include:
- Gilead Sciences Inc.
- Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck & Co. Inc.
- Abbott Laboratories
- AbbVie Inc.
- Arbutus Biopharma Corporation
- Aspen Pharmacare Holdings Limited
- Aurobindo Pharma Limited
- And many more…
View More On The Hepatitis Drugs Market Report 2024 – https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Advancements in Hepatitis Treatment: Collaborative Launch of New Medications
New Product Launches
One notable trend in the hepatitis drugs market is the emphasis on new product launches. Key players are actively introducing innovative treatments to bolster their market standing. A prime example is the collaborative effort by Malaysian entities and international organizations in creating a secure and efficient hepatitis C treatment. This South-South collaboration, with non-profit involvement, marks a significant milestone in hepatitis medication development.

Strategic Acquisition by Gilead Sciences
Gilead Sciences, a leading biopharmaceutical company, made strategic strides in March 2021 by acquiring MYR GmbH for $1.55 billion (€1.45 billion) in cash. This acquisition positions Gilead to leverage MYR GmbH’s new drugs, expanding its market reach for enhanced hepatitis treatment. MYR GmbH specializes in developing inhibitors for chronic hepatitis B and D infections.

Segmentation for a Comprehensive Understanding
The hepatitis drugs market is segmented based on various parameters, providing a comprehensive view of its dynamics:
1. By Drug Class:
  - Interferon Alphas
  - HIV NRTIs
  - Nucleotide Polymerase/NS5A Inhibitor Combinations
  - Hepatitis C Protease/NS5A Inhibitor Combinations
  - NS5A Inhibitors
  - Nucleotide Polymerase Inhibitors
  - Nucleoside Analogue Antivirals
  - Thrombopoiesis Stimulating Agents
2. By Route Of Administration:
  - Oral
  - Injection
3. By Distribution Channel:
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
4. By Application:
  - Hepatitis A
  - Hepatitis B
  - Hepatitis C
  - Hepatitis D
  - Hepatitis E
Regional Dynamics
North America led the hepatitis drugs market in 2023, while Asia-Pacific is expected to be the fastest-growing region in the forecast period. This regional shift underscores the global nature of the hepatitis epidemic and the importance of addressing it on a worldwide scale.

In conclusion, the hepatitis drugs market is on an upward trajectory, fueled by research investments, strategic collaborations, and innovative product launches. With a focus on eliminating viral hepatitis as a public health threat, the industry is poised for sustained growth and advancements in treatment options.

Request A Sample Of The Global Hepatitis Drugs Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6889&type=smp
January 18, 2024
Heparin Market Forecast 2024: Forecast Market Size, Drivers And Key Segments
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The heparin market has experienced robust growth in recent years, with significant expansions anticipated in both 2024 and 2028.

Market Statistics
- In 2023, the market size reached $9.29 billion, set to grow to $9.86 billion in 2024 at a CAGR of 6.2%.
- Further growth is forecasted, reaching $12.92 billion in 2028 with a CAGR of 7.0%.
Historical Drivers
- Increased prevalence of cardiovascular diseases.
- Advances in surgical procedures necessitating anticoagulation.
- Growth in the aging population.
- Rise in deep vein thrombosis cases.
- Expansion of applications in renal dialysis.
Driving Forces Behind Heparin Market Growth
Rising Prevalence of Chronic Diseases
The escalating prevalence of chronic diseases is a major catalyst for the growth of the heparin market. Chronic conditions, lasting over a year, demand constant medical attention, leading to increased use of heparin in surgeries and medical treatments.
- Lifestyle changes and unhealthy eating habits contribute to chronic diseases.
- The International Diabetes Federation predicts a surge in diabetes cases, driving demand for heparin.
- Chronic diseases are a global concern, necessitating a steady supply of heparin.
Key Market Players
- Baxter International Inc.
- B. Braun Medical Inc.
- Dr. Reddy’s Laboratories Ltd.
- Fresenius SE & Co. KGaA.
- Leo Pharma A/S.
- And more.
Product Advancements Driving Growth
A key trend influencing the heparin market is the focus on product advancement. Key players are investing in research and development to create advanced heparin products, enhancing precision and convenience.
- Fresenius Kabi USA launches Freeflex IV bags for sodium heparin administration.
- Acquisition of Ivenix Inc. by Fresenius Kabi boosts portfolio quality and sustainability.
Market Segmentation
1. Product Types:
  - Unfractionated Heparin.
  - Low Molecular Weight Heparin (LMWH).
  - Ultra-Low Molecular Weight Heparin (ULMWH).
2. Source:
  - Bovine.
  - Porcine.
3. Route of Administration:
  - Intravenous.
  - Subcutaneous.
4. Applications:
  - Venous Thromboembolism.
  - Atrial Fibrillation.
  - Renal Impairment.
  - Coronary Artery Disease.
  - Other Applications.
5. Distribution Channels:
  - Hospital Pharmacies.
  - Drug Stores & Retail Pharmacies.
  - Online Pharmacies.
View More On The Heparin Market Report 2024 – https://www.thebusinessresearchcompany.com/report/heparin-global-market-report

Regional Dynamics
North America Dominates
- North America led the heparin market in 2023.
- The region showcases a robust healthcare infrastructure and demand for advanced medical interventions.
Asia-Pacific Emerges
- Asia-Pacific is poised to be the fastest-growing region.
- Increasing healthcare needs and emerging markets contribute to the region’s growth.
Future Trends and Opportunities
- Technological Advancements:
  - Ongoing advancements in heparin production.
  - Integration of digital technologies in heparin administration.
- Emphasis on Safety and Bioavailability:
  - Focus on producing safer and more bioavailable heparin.
- Biosimilars and Alternatives:
  - Adoption of biosimilars.
  - Exploration of heparin alternatives and substitutes.
As the heparin market evolves, these trends and growth drivers pave the way for a promising future, aligning with the increasing global demand for advanced healthcare solutions. The industry’s ability to adapt to emerging challenges and capitalize on opportunities will play a pivotal role in shaping its trajectory.

Request A Sample Of The Global Heparin Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6684&type=smp
January 18, 2024
5 Key Insights On The Medical Equipment Calibration Services Market 2024
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Medical Equipment Calibration Services Global Market Report 2024, the medical equipment calibration services market is expected to show significant growth in the forecast period.
- Market Size Overview: The medical equipment calibration services market has experienced rapid The medical equipment calibration services market has experienced remarkable growth in recent years, and the trajectory is set to continue. With a surge from $1.48 billion in 2023 to $1.64 billion in 2024 at a CAGR of 11.2%, the sector is on a robust upward swing. Let’s delve into the factors driving this growth and the trends shaping the future of medical equipment calibration services.
- I. Market Growth Dynamics
- Global Health Preparedness and Regulatory Compliance
- The historic growth is underpinned by a focus on global health preparedness.
- Remote calibration services gain prominence for accessibility and efficiency.
- Patient-centric care and aging medical equipment contribute to market expansion.
- Regulatory compliance mandates drive the demand for calibration services.
- Forecast Period Projections
- The market is poised to reach $2.45 billion in 2028 with a CAGR of 10.6%.
- Digital health expansion and eco-friendly calibration practices play pivotal roles.
- Preventive maintenance and clinical laboratory accreditation become focal points.
- Patient safety remains a critical driver of growth.
- Emerging Trends in the Forecast Period
- Telehealth equipment calibration gains prominence.
- Remote calibration support becomes integral to service offerings.
- Digital calibration solutions and IoT-enabled calibration reshape the landscape.
- AI-enhanced calibration emerges as a transformative trend.
View More On The Medical Equipment Calibration Services Market Report 2024 – https://www.thebusinessresearchcompany.com/report/medical-equipment-calibration-services-global-market-report
- II. Elevated Healthcare Infrastructure Investment
- Driving Force Behind Growth
- Rising investments in healthcare infrastructure propel market expansion.
- Healthcare market in India projected to triple to USD 133.44 billion by 2022.
- U.S. healthcare spending reaches $4.1 trillion in 2020, growing at 9.7%.
- Ensuring safety and effectiveness of medical devices crucial for public health.
- Key Players in the Market
- Transcat Inc., Tektronix Inc., Fluke Biomedical LLC lead the industry.
- Other significant players include NS Medical Systems, JM Test Systems LLC, and more.
- III. Strategic Partnerships and Collaborations
- Innovation through Collaboration
- Partnerships and collaborations gain traction for market players.
- Ultimo partners with Fluke Biomedical to enhance efficiency for healthcare organizations.
- Tektronix Inc. collaborates with Coherent Solutions to provide integrated optical communications platforms.
- A Case in Point: Ellab’s Acquisition
- Ellab’s acquisition of Arena Instrumentation Limited enhances its capabilities.
- Arena’s expertise in field calibration complements Ellab’s thermal validation and monitoring products.
- The acquisition strengthens Ellab’s position in the market and expands Arena’s reach.
- IV. Market Segmentation
- Service Segmentation
- In-house, Third-Party Services, Original Equipment Manufacturer (OEM).
- Equipment Segmentation
- Fetal Monitors, Imaging Equipment, Vital Sign Monitors, Infusion Pumps, Cardiovascular Monitors, Ventilators, Other Equipment.
- End User Segmentation
- Hospitals, Clinical Laboratories, Other End Users.
- V. Regional Landscape
- Market Dominance and Growth
- North America leads the market in 2023.
- Asia-Pacific emerges as the fastest-growing region in the forecast period.
- In conclusion, the medical equipment calibration services market is evolving dynamically, driven by global health initiatives, technological advancements, and strategic collaborations. As healthcare infrastructure investments soar, the demand for reliable calibration services is set to skyrocket. The market players, through innovation and partnerships, are not only meeting these demands but also shaping the future of healthcare calibration services. The future holds exciting prospects, with the integration of digital solutions, AI, and IoT set to revolutionize the calibration landscape.
Request A Sample Of The Global Medical Equipment Calibration Services Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6744&type=smp
January 17, 2024
Key Trends And Drivers In The Microneedle Drug Delivery Systems Market 2024
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The microneedle drug delivery systems market has undergone rapid growth, surging from $4.32 billion in 2023 to an anticipated $5.13 billion in 2024, showcasing an impressive CAGR of 18.7%. This growth, rooted in pain-free drug delivery, enhanced patient compliance, and diverse applications in chronic disease management, cosmetics, and aesthetics, is set to propel the market to new heights, reaching $9.82 billion by 2028, with a projected CAGR of 17.6%.

Growing Demand For Microneedle Drug Delivery Systems Driven By Vaccine Research:
- Alternative Vaccination Method:The increasing demand for vaccination research has become a key driver for the microneedle drug delivery systems market. Microneedle patches offer a painless alternative for vaccine administration, gaining prominence in flu, measles, and most notably, COVID-19 vaccines.
- Global Vaccination Statistics:A Bloomberg report indicates over 3.98 billion vaccine doses administered across 180 countries until July 2021, highlighting the increasing adoption of microneedle drug delivery technology globally.
Innovation In Microneedle Drug Delivery With Nanopass Launches Micronjet 600:
- Innovative Products:Major players in the microneedle drug delivery systems market are focused on innovation, exemplified by products like the MicronJet 600. Launched by NanoPass Technologies Ltd., MicronJet 600 is a microneedle-based device for intradermal drug delivery, earning FDA clearance as the first true (<1 mm) microneedle for intradermal delivery below the skin surface.
- Diverse Applications:MicronJet 600 serves as a versatile platform for drug delivery, accommodating vaccines, drugs, peptides, and dermal fillers, showcasing the adaptability and potential of microneedle technology.
Read More On The Microneedle Drug Delivery Systems Market Report 2024 – https://www.thebusinessresearchcompany.com/report/microneedle-drug-delivery-systems-global-market-report

Terasaki Institute Partners With Pharmather For Psychedelic Microneedle Patch Development:
- Strategic Partnerships:In February 2021, the Terasaki Institute partnered with PharmaTher to advance microneedle technology in the development of a psychedelic microneedle patch. This collaboration aims to create more efficient and effective delivery methods for psychedelic pharmaceuticals.
- Efficient Drug Delivery:The partnership with PharmaTher, a Canadian pharmaceutical company specializing in microneedle drug delivery systems, underscores the expanding applications of microneedles beyond traditional drug and vaccine delivery.
Market Segmentation: The microneedle drug delivery systems market is segmented into various categories:
1. By Technology:Hollow, Porous, Solid, and Other Technologies.
2. By Application:Drug Delivery, Vaccine Delivery, and Other Applications.
3. By End-User:Diagnostics Laboratories, Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, and Other End-Users.
Major Trends Shaping the Future:
- Smart Microneedles:The integration of smart microneedles marks a significant trend, enhancing the functionality and capabilities of microneedle drug delivery systems.
- Advancements in Material Science:Ongoing developments in material science contribute to the creation of more efficient and biocompatible microneedle technologies.
- Advancements in Wearable Technology:The synergy between microneedle technology and wearable devices promises to revolutionize drug delivery and patient monitoring.
- Biodegradable Materials:The shift towards biodegradable materials in microneedle development aligns with environmentally conscious practices.
- Continuous Glucose Monitoring:The incorporation of microneedles in continuous glucose monitoring reflects the expanding scope of these systems in managing chronic conditions.
Regional Dynamics:
- North America Leading Innovation:In 2023, North America emerged as the largest region in the microneedle drug delivery systems market, showcasing the region’s leadership in adopting and advancing this groundbreaking technology.
- Asia-Pacific’s Potential:Asia-Pacific is anticipated to be the fastest-growing region in the forecast period, signifying the global reach and potential of microneedle drug delivery systems.
Conclusion: As the microneedle drug delivery systems market continues to surge, driven by vaccine research, technological innovations, and strategic partnerships, it marks a paradigm shift in drug delivery methods. The ability to provide pain-free, efficient, and diverse applications positions microneedle technology as a transformative force in healthcare. With smart microneedles, advancements in material science, and a focus on sustainability, the future promises even more breakthroughs, making microneedle drug delivery systems a cornerstone in modern healthcare.

Request for A Sample Of The Global Microneedle Drug Delivery Systems Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5338&type=smp
January 17, 2024
Growth Trajectory Of The Minimally Invasive Surgery Market 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The minimally invasive surgery market has demonstrated robust growth, expanding from $57.7 billion in 2023 to an estimated $63.41 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 9.9%. This growth in the historic period is attributed to various factors such as increased patient awareness, reduced hospital stay, lower infection risk, surgeon training proficiency, and the prevalence of chronic diseases.
- Chronic Diseases Driving Demand:The surge in chronic diseases, including cancer, neurological disorders, and cardiovascular diseases, is a significant catalyst for the demand in the minimally invasive surgery market. These long-lasting illnesses often necessitate ongoing medical attention, leading patients to seek less invasive surgical solutions for enhanced care and faster recovery.
- Impact of Lifestyle Changes:Changing lifestyles, dietary habits, and obesity contribute to the rise in chronic conditions. Minimally invasive surgeries provide several advantages, including less post-operative pain, shorter hospital stays, faster recovery times, and minimal scarring, addressing the specific needs of patients dealing with chronic illnesses.
- Global Impact of Chronic Diseases:According to a report by the National Library of Medicine, the number of individuals aged 50 and older with chronic illnesses in the United States is projected to increase by 99.5% by 2050. This emphasizes the critical role of minimally invasive surgery in addressing the healthcare challenges posed by chronic diseases.
View More On The Minimally Invasive Surgery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report

Technological Advancements Drive Surge In Minimally Invasive Surgery Market

Technological advancements play a pivotal role in the growth of the minimally invasive surgery market. As science and technology progress, there is a heightened demand for specialized medical care and treatment quality. Innovations in optics, instrumentation, materials, robotics, and computer systems contribute to the increased adoption of minimally invasive surgery techniques.
- Focus on Technological Solutions:Major companies in the market are investing in the development of cutting-edge technological solutions. For example, Ethicon, part of Johnson & Johnson, introduced the ECHELONTM+ stapler with GST reloads, incorporating gripping surface technology (GST) reloads for more consistent compression and a new motor with dynamic firing for optimized speed in thick tissue.
Hologic, Inc. Enhances Surgical Portfolio With Acquisition Of Bolder Surgical

Strategic acquisitions are shaping the landscape of the minimally invasive surgery market. In October 2021, Hologic, Inc., a US-based medical technology company, acquired Bolder Surgical for $160 million. This acquisition further strengthens Hologic’s surgical portfolio by integrating Bolder’s advanced vessel sealing and dissection tools used in laparoscopic procedures.
- Broadening Surgical Portfolio:Hologic’s acquisition of Bolder Surgical highlights the industry trend of expanding capabilities through strategic acquisitions. The addition of advanced energy vessel sealing surgical devices enhances Hologic’s ability to provide comprehensive solutions for minimally invasive surgical procedures.
Market Segmentation: A Comprehensive Overview

The minimally invasive surgery market is segmented based on devices, products, applications, and end-users, providing a comprehensive understanding of the diverse components within the industry.
1. Device Segmentation:Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring And Visualization Devices.
2. Product Segmentation:Surgical Devices, Laparoscopy Devices, Monitoring And Visualization Devices.
3. Application Segmentation:Cardiac, Gastrointestinal, Orthopedic, Vascular, Gynecological, Urological, Cosmetic, Dental.
4. End-User Segmentation:Hospitals And Specialty Clinics, Ambulatory Surgery Centers.
- Regional Dominance:North America emerged as the largest region in the minimally invasive surgery market in 2023, underlining the region’s substantial contribution to the overall market dynamics.
In conclusion, the minimally invasive surgery market’s trajectory is marked by its ability to address the rising prevalence of chronic diseases, fueled by advancements in technology and strategic acquisitions. As the market continues to evolve, these trends will play a crucial role in shaping its future, offering enhanced precision, patient care, and a broader range of medical solutions.

Request A Sample Of The Global Minimally Invasive Surgery Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7768&type=smp
January 17, 2024
How Is The Minimally Invasive Surgical Instruments Market Expected To Grow Through 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Minimally Invasive Surgical Instruments Global Market Report 2024, the minimally invasive surgical instruments market is expected to show promising growth in the forecast period.
1. Introduction
The minimally invasive surgical instruments market has experienced rapid growth, escalating from $36.6 billion in 2023 to a projected $40.42 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 10.5%. This expansion can be attributed to several factors, including an aging population, an increase in chronic diseases, heightened research and development investment in healthcare, improved healthcare infrastructure, and a surge in medical tourism.
1. Projected Growth and Key Drivers
2. Anticipated Momentum
The market is poised for robust growth, with a projected escalation to $59.17 billion in 2028, driven by a Compound Annual Growth Rate (CAGR) of 10.0%. Key drivers in this forecast period include an increasing surgical volume, growing healthcare expenditure, rising disposable income, and a demand for shorter hospital stays.
1. Key Growth Drivers
2. Increasing Surgical Volume:Surge in demand for various minimally invasive surgical procedures.
3. Growing Healthcare Expenditure:Higher investment in healthcare infrastructure and services.
4. Rising Disposable Income:Affordability driving patient preference for advanced surgical techniques.
5. Demand for Shorter Hospital Stays:Patients seeking efficient and less invasive medical interventions.
III. Surge in Minimally Invasive Surgical Procedures Drives Market Growth
1. Preference for Minimally Invasive Surgery
The escalating number of surgical procedures, including adrenalectomy, brain surgery, heart surgery, kidney transplant, spine surgery, and plastic and cosmetic surgery, is driving the growth of the minimally invasive surgical instruments market.
1. Statistical Insights
- In April 2022, the Aesthetic Society reported a 54% increase in surgical procedures for plastic and cosmetic surgery in 2021, with an average plastic surgeon conducting 320 surgical operations.
1. Industry Leaders
- Major companies in the market include Abbott Laboratories Inc., Intuitive Surgical Inc., Boston Scientific Corporation, and Johnson & Johnson Services Ltd.
1. Innovation in Minimally Invasive Surgical Instruments
2. Surgical Visualization Platforms
Innovation is evident in the introduction of surgical visualization platforms, providing high-quality, real-time images of the surgical site. Olympus Corporation’s VISERA ELITE III, launched in September 2022, integrates multiple observation modes and fluorescence-guided surgery in 4K, enhancing surgical outcomes and procedural learning curves.
1. Enhanced Surgical Visualization
- Anticipated software upgrades are expected to further enhance surgical imaging technology, offering customization for various surgical requirements while reducing overall costs.
1. Industry Expansion and Collaborations
2. Erbe Electromedicine’s Acquisition
In April 2021, Erbe Elektromedizin acquired Maxer Endoscopy GmbH, expanding its surgical endoscopy business. This strategic move allows Erbe to utilize 4K and fluorescence-guided devices for endoscopic and open operations, enhancing performance in minimally invasive surgery.

View More On The Minimally Invasive Surgical Instruments Market Report 2024 – https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgical-instruments-global-market-report
1. Market Segmentation
The market is segmented based on various criteria, offering a comprehensive understanding of its diverse components.
1. By Product
2. Handheld Instruments
3. Inflation Systems
4. Cutter Instruments
5. Guiding Devices
6. Electrosurgical Devices
7. Auxiliary Instruments
8. Type of Procedure Outlook
9. Robotic
10. Non-Robotic
11. By Application
12. Cardiothoracic Surgery
13. Gastrointestinal Surgery
14. Orthopedic Surgery
15. Gynecological Surgery
16. Cosmetic & Bariatric Surgery
17. Vascular Surgery
18. Urological Surgery
19. By End User
20. Hospitals
21. Ambulatory Surgical Clinics
22. Research Institutes
VII. Regional Dynamics

North America held the largest share in the minimally invasive surgical instruments market in 2023, while Asia-Pacific is expected to be the fastest-growing region in the forecast period.

VIII. Conclusion

As the minimally invasive surgical instruments market continues to expand, innovations in technology, strategic acquisitions, and a focus on patient-centric approaches are pivotal. Stakeholders in healthcare must adapt to these evolving trends to ensure the delivery of efficient, less invasive, and technologically advanced surgical solutions.

Request A Sample Of The Global Minimally Invasive Surgical Instruments Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5656&type=smp
January 17, 2024
Comprehensive Analysis On Size, Share, And Drivers Of The Mixed Reality in Healthcare Market
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The mixed reality in healthcare market has experienced exponential growth, surging from $0.47 billion in 2023 to an anticipated $0.71 billion in 2024, showcasing an impressive CAGR of 51.7%. This surge in the historic period is credited to advancements in medical training, patient education, rehabilitation, physical therapy, and the pivotal role it plays in chronic disease management and reducing radiation exposure. Looking ahead, the market is poised for exponential growth, projecting a size of $4.39 billion by 2028, with a remarkable CAGR of 57.7%. This growth is fueled by global health initiatives, regulatory frameworks, holographic telemedicine, workflow optimization, and the rise of remote consultations.

Growing Elderly Population Propels Mixed Reality In Healthcare Market Growth:
- Elderly Population Dynamics:The increase in the elderly population, aged 65 and over, is a significant driver for the mixed reality in healthcare market. This demographic is more prone to diseases requiring surgery, and mixed reality aids surgeons in visualizing patient anatomy alongside MRI and CT scan data.
- Population Statistics:In the United States, over 56 million adults are aged 65 and above, constituting 16.9% of the total population. By 2030, more than 73.1 million older individuals are expected, emphasizing the growing need for healthcare solutions for the elderly.
View More On The Mixed Reality in Healthcare Market Report 2024 – https://www.thebusinessresearchcompany.com/report/mixed-reality-in-healthcare-global-market-report

Technological Advancements: 8Chili Inc. Collaborates With Apollo Hospitals Group:
- Metaverse Integration:Technological advancements, particularly in virtual reality (VR), are shaping the landscape of mixed reality in healthcare. In a notable collaboration, Apollo Hospitals Group joined forces with 8chili Inc. to enhance patient outcomes through virtual reality counseling in the metaverse.
- Virtual Reality Patient Counseling:The collaboration focuses on using virtual reality for patient counseling before and after surgery, creating a personalized and immersive experience that positively impacts patient outcomes. This approach involves patients in virtual reality-based activities, enhancing their emotional control and overall satisfaction.
Ge HealthCare’s Acquisition Of Bk Medical:
- End-To-End Surgical Visualization:In a strategic move, GE Healthcare acquired BK Medical for $1.45 billion in December 2021. This acquisition aims to create an end-to-end offering for surgical visualization, combining GE’s pre- and post-operative ultrasound capabilities with BK Medical’s expertise in real-time surgical visualization.
- Intraoperative Imaging and Surgical Navigation:BK Medical, a US-based company, specializes in intraoperative imaging and surgical navigation, offering mixed reality services that complement GE Healthcare’s commitment to comprehensive healthcare solutions.
Market Segmentation: The mixed reality in healthcare market is segmented into various categories:
1. By Device Types:AR Devices and VR Devices.
2. By Component:Hardware, Software, Content, and Application.
3. By Application:Surgery and Surgery Simulation, Patient Care Management, Fitness Management, Medical Training and Education, and Other Applications.
4. By End-Users:Hospitals, Surgical Centers and Medical Institutes, and Other End Users.
Regional Dynamics:
- North America Leading the Way:In 2023, North America emerged as the largest region in the mixed reality in healthcare market, showcasing the region’s advanced adoption of mixed reality technologies in healthcare.
- Asia-Pacific’s Rapid Growth:Asia-Pacific is projected to be the fastest-growing region in the forecast period, reflecting the increasing integration of mixed reality solutions in the healthcare sector across the region.
Conclusion: The surge of mixed reality in healthcare heralds a new era in medical technology, with exponential growth driven by innovative applications in surgery, patient care management, and medical training. The elderly population’s growing healthcare needs, coupled with technological advancements and strategic collaborations, underscore the transformative potential of mixed reality in reshaping the healthcare landscape. As we venture into the future, the integration of artificial intelligence, virtual clinical trials, wearable mixed reality devices, augmented preoperative planning, and real-time language translation will further propel this dynamic market forward, promising enhanced patient care and improved healthcare outcomes.

Request A Sample Of The Global Mixed Reality in Healthcare Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6935&type=smp
January 17, 2024
Understand How The Mobile Imaging Services Market Is Poised To Grow Through 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Mobile Imaging Services Global Market Report 2024, the mobile imaging services market is expected to show significant growth in the forecast period.

The mobile imaging services market has witnessed substantial growth, with the market size increasing from $17.93 billion in 2023 to a projected $19.01 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 6.0%. The growth in the historic period is attributed to factors such as the aging population, cost-efficiency, emergency medical services, disease screening programs, chronic disease management, and regulatory frameworks.
- Global Impact of Chronic Diseases:Chronic diseases, including cancer, neurological disorders, and cardiovascular diseases, are on the rise, driving the demand for mobile imaging services. These long-term health issues require continuous medical attention and contribute significantly to global mortality rates. Mobile imaging services play a crucial role in disease management, offering screenings through technologies like X-Ray, EKG, and ultrasound.
- Chronic Disease as a Global Health Challenge:The United Nations predicts that chronic diseases will contribute to 70% of total global deaths by 2030. This underscores the urgent need for advanced imaging solutions to aid in early detection, monitoring, and management of chronic conditions.
- Market Players:Key companies contributing to the mobile imaging services market include Accurate Imaging Inc., Alliance HealthCare Services Inc., Axiom Mobile Imaging, and Carestream Health, among others. These entities are at the forefront of providing innovative solutions to meet the growing demand for mobile imaging services.
View More On The Mobile Imaging Services Market Report 2024 – https://www.thebusinessresearchcompany.com/report/mobile-imaging-services-global-market-report

Photonis And Telops Merger: Advancing Imaging Solutions

Strategic collaborations and acquisitions are emerging as a key trend in the mobile imaging services market. In April 2023, Photonis, a France-based electro-optical detection and imaging systems manufacturer, announced its definitive agreement to acquire Telops, a Canadian developer of high-performance imaging systems. This merger aims to deliver advanced imaging products to Business-to-Business (B2B) customers, leveraging component manufacturing mastery, expansive geographical reach, and advanced technological capabilities.
- Innovation through Collaboration:The merger of Photonis and Telops exemplifies the industry’s focus on innovation through strategic partnerships. Combining expertise and resources allows for the development of cutting-edge imaging solutions that meet the evolving needs of B2B customers.
Dispatch Health’s Acquisition Expands In-Home Medical Care Services

In April 2021, DispatchHealth, a US-based provider of in-home medical care services, acquired Professional Portable X-ray (PPX) to enhance its services and expand its home care system. PPX, a mobile radiology service provider, contributes to DispatchHealth’s goal of building the largest home care system.
- Meeting the Demand for In-Home Services:The acquisition of PPX reflects the growing trend of in-home medical care services. DispatchHealth aims to meet the rising demand for convenient and accessible healthcare solutions, further emphasizing the importance of mobile imaging services in the evolving healthcare landscape.
Market Segmentation: Understanding Diverse Needs

The mobile imaging services market is segmented based on product type and end user, offering a comprehensive understanding of the diverse needs within the industry.
1. Product Type:The market includes X-ray, Ultrasound, CT, MRI, Mammography, and Bone Densitometry.
2. End User:Segmentation by end user encompasses Hospitals and Private Clinics, Home Healthcare Providers, Rehabilitation Centers, Geriatric Care and Hospice Agencies, Sports Organizations, and Other End Users.
- Regional Dominance:In 2023, North America emerged as the largest region in the mobile imaging services market, highlighting the region’s significant contribution to the overall market dynamics.
In conclusion, the mobile imaging services market’s growth trajectory is marked by its crucial role in addressing the rising prevalence of chronic diseases, strategic collaborations for advanced imaging solutions, and the expansion of in-home medical care services. As the market continues to evolve, these trends will shape its future landscape, emphasizing the importance of accessible and innovative healthcare solutions.

Request A Sample Of The Global Mobile Imaging Services Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5145&type=smp
January 17, 2024
What Is The Forecast Growth Rate For The Mortuary Equipment Market?
The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.
1. Introduction
The mortuary equipment market has witnessed robust growth, surging from $1.05 billion in 2023 to a projected $1.14 billion in 2024, showcasing a Compound Annual Growth Rate (CAGR) of 8.6%. This growth is attributed to factors such as healthcare infrastructure, population growth, funeral industry demands, regulatory compliance, and the impact of natural disasters.
1. Projected Growth and Key Drivers
2. Anticipated Surge
The market is poised for rapid expansion, with a projected growth to $1.67 billion in 2028, reflecting a higher CAGR of 10.1%. This growth is expected due to several influential factors, including an aging population, military and law enforcement requirements, increased demand for cremation services, cultural diversity, and heightened focus on pandemic preparedness.
1. Key Growth Drivers
2. Aging Population:Higher mortality rates due to an aging demographic.
3. Military and Law Enforcement:Specific equipment needs for these sectors.
4. Cremation Services:Growing preference for cremation as an end-of-life option.
5. Cultural Diversity:Varied funeral practices influencing equipment requirements.
6. Pandemic Preparedness:Increased focus on handling mass fatalities.
III. Rising Mortality Rates Drive Market Growth
1. Mortality Rate Impact
The surge in mortality rates is a pivotal factor driving the growth of the mortuary equipment market. As mortality rates increase, so does the demand for essential equipment such as body bags, mortuary stretchers, lifting carts, mortuary washing units, and autopsy tables.
1. Statistical Insights
- According to the Centers for Disease Control and Prevention (CDC), the age-adjusted death rate in the United States increased by 5.3% from 2020 to 2021.
- Mortuary equipment market leaders include Ferno-Washington Inc., Flexmort, and LEEC Limited.
Read More On The Mortuary Equipment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/mortuary-equipment-global-market-report
1. Innovative Trends in Mortuary Equipment
2. Green Burial Practices
Companies are embracing sustainable practices, with innovations like biodegradable mushroom coffins that biodegrade in just 45 days. Loop Biotech, a Dutch startup, introduced these environmentally friendly coffins, combining upcycled hemp with mycelium.
1. Digital Records and Management
The industry is witnessing a shift towards digitalization, with an increasing focus on managing mortuary records electronically for enhanced efficiency and accessibility.
1. Remote Autopsies
Advancements in technology have enabled remote autopsies, allowing pathologists to conduct examinations without physical presence, reducing the need for physical handling of bodies.
1. Smart Mortuary Equipment
Incorporating smart technologies into mortuary equipment, such as temperature-controlled refrigerators and automated lifting systems, is a notable trend in the industry.
1. Industry Consolidation and Expansion
2. Charterhouse Capital Partners’ Acquisition
In January 2023, Charterhouse Capital Partners LLP acquired Facultatieve Group, consolidating Funecap’s position in the Dutch crematoria management market and expanding its crematoria management business in Germany and Switzerland.
1. Market Segmentation
The mortuary equipment market is segmented based on various criteria, offering a comprehensive understanding of its diverse components.
1. By Product Type
2. Refrigerators And Freezers
3. Autopsy And Dissection Tables
4. Cadaver Lifts
5. Cadaver Trolleys
6. Other Types
7. By Application
8. Manual
9. Automated
10. By End User
11. Hospitals
12. Academic Institutions
13. Research Organizations
14. Forensic Laboratories
15. Other End-Users
VII. Regional Dynamics

North America dominated the mortuary equipment market in 2023, with Asia-Pacific anticipated to be the fastest-growing region in the forecast period.

VIII. Conclusion

The mortuary equipment market’s evolution reflects the dynamic interplay of demographic shifts, technological innovations, and industry consolidation. As the market continues to grow, stakeholders must stay attuned to emerging trends and adapt strategies to meet evolving demands in this sensitive and essential sector.

Request for A Sample Of The Global Mortuary Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=6047&type=smp
January 17, 2024
Key Insights On The Medical Tubing Market 2024 – Size, Driver, And Major Players
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Medical Tubing Global Market Report 2024, the medical tubing market is expected to show significant growth in the forecast period.
1. Introduction
The medical tubing market has experienced robust growth, surging from $11.95 billion in 2023 to a projected $13.25 billion in 2024, showcasing a Compound Annual Growth Rate (CAGR) of 10.9%. This surge can be attributed to factors such as medical device manufacturing, infection control, cardiovascular procedures, surgical applications, and the trend towards miniaturization and microfluidics.
1. Projected Growth and Key Drivers
2. Anticipated Expansion
The market is poised for rapid growth, with a projected escalation to $21.03 billion in 2028, driven by a Compound Annual Growth Rate (CAGR) of 12.2%. Key drivers in this forecast period include precision medicine, telemedicine services, biodegradable materials, global health initiatives, and the increasing geriatric population.
1. Key Growth Drivers
1. Precision Medicine: Tailoring medical treatment to individual characteristics.
2. Telemedicine Services: Expanding reach and accessibility of healthcare.
3. Biodegradable Materials: Growing emphasis on environmentally friendly solutions.
4. Global Health Initiatives: Addressing healthcare needs on a global scale.
5. Geriatric Population: Increasing demand for medical services for the elderly.
III. Escalation of Respiratory Ailments Drives Market Growth
1. Impact of Respiratory Diseases
The rising prevalence of respiratory diseases, including asthma, lung cancer, and pulmonary fibrosis, is a driving force behind the growth of the medical tubing market. These diseases, often caused by factors like tobacco smoking and air pollution, are leading to an increased demand for medical tubes, particularly in ventilators that aid breathing.
1. Statistical Insights
- The percentage of Chronic Obstructive Pulmonary Disease (COPD) among adults in the USA increased from 4.6% in 2020 to 5.0% in 2021, according to the Centers for Disease Prevention and Control (CDC).
1. Industry Leaders
- Major companies in the market include Saint-Gobain S.A., W.L. Gore & Associates Inc., and Teleflex Medical OEM LLC.
View More On The Medical Tubing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/medical-tubing-global-market-report
1. Innovative Product Development Reshaping the Market
2. Key Trend: Product Innovation
Product innovation stands out as a prominent trend in the medical tubing market. Key players are focusing on launching innovative medical tubes with advanced features to enhance effectiveness. One notable innovation is the braided medical tube, revolutionizing the capabilities of catheters and medical tubing.
1. Braided Medical Tubes
- Braided tubes improve flexibility and strength in medical equipment.
- Utilized in cardiovascular and neurovascular surgery, as well as endoscopic treatments.
1. Industry Innovation Example
- In January 2021, Zeus Industrial Products, Inc. launched braid and coil-reinforced polyamide tubing, enhancing catheter design capabilities.
1. Industry Expansion and Collaborations
2. Strategic Acquisition: Catheter and Medical Design
In March 2021, Catheter and Medical Design acquired VitalDyne Medical, strengthening its position in the global medical device industry. This acquisition expanded capabilities in laser cutting, welding, micromachining, and final device production.
1. Industry Collaboration Example
- VitalDyne Medical, a manufacturer of sophisticated catheter solutions, adds valuable expertise to Catheter and Medical Design’s manufacturing capabilities.
1. Market Segmentation
The market is segmented based on various criteria, offering a comprehensive understanding of its diverse components.
1. By Product
1. Silicone
2. Polyolefins
3. Polyvinyl Chloride
4. Polycarbonates
5. Fluoropolymers
6. Other Products
1. By Application
1. Bulk Disposable Tubing
2. Drug Delivery Systems
3. Catheters
4. Biopharmaceutical Laboratory Equipment
5. Other Applications
1. By End-User
1. Hospitals
2. Clinics
3. Ambulatory Surgical Centers
4. Medical Labs
5. Other End-Users
VII. Regional Dynamics

North America emerged as the largest region in the medical tubing market in 2023, while Asia-Pacific is expected to be the fastest-growing region in the forecast period.

VIII. Conclusion

The growth trajectory of the medical tubing market is dynamic, driven by a range of factors from innovative product development to the escalating demand for respiratory care. As the industry continues to evolve, stakeholders must stay abreast of these trends and collaborate to ensure the delivery of advanced and effective healthcare solutions.

Request A Sample Of The Global Medical Tubing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6688&type=smp
January 17, 2024